🎁 Black Friday: up to 50% off of annual plans
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
121.40
-2.62 (-2.11%)
Nov 20, 2026, 4:00 PM EST - Market closed

Protagonist Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
551.6946.02434.436026.5827.36
Revenue Growth
163.69%-89.41%624.05%125.72%-2.84%-4.44%
Gross Profit
550.5946.02434.436026.5827.36
Selling, General & Admin
51.0644.8543.4633.4931.7427.2
Research & Development
176.43159.29138.13120.16126.22126.01
Operating Expenses
227.5204.14181.59153.65157.95153.2
Operating Income
323.1-158.13252.84-93.65-131.37-125.85
Interest & Investment Income
27.3228.7926.3214.94.060.44
Currency Exchange Gain (Loss)
-0.2----0.08-0.15
Other Non Operating Income (Expenses)
0.030.030.25-0.2--
EBT Excluding Unusual Items
350.24-129.31279.41-78.96-127.39-125.55
Pretax Income
350.25-129.31279.41-78.96-127.39-125.55
Income Tax Expense
7.990.844.22---
Net Income
342.26-130.15275.19-78.96-127.39-125.55
Net Income to Common
342.26-130.15275.19-78.96-127.39-125.55
Net Income Growth
645.53%-----
Shares Outstanding (Basic)
656462574946
Shares Outstanding (Diluted)
696465574946
Shares Change
8.19%-2.31%14.65%15.74%5.87%34.67%
EPS (Basic)
5.24-2.054.47-1.39-2.60-2.71
EPS (Diluted)
4.93-2.054.23-1.39-2.60-2.71
EPS Growth
584.11%-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
109.1556.08182.8-70.85-108.93-108.97
Free Cash Flow Per Share
1.570.882.81-1.25-2.22-2.35
Gross Margin
99.80%100.00%100.00%100.00%100.00%100.00%
Operating Margin
58.56%-343.63%58.20%-156.09%-494.24%-460.01%
Profit Margin
62.04%-282.83%63.34%-131.59%-479.26%-458.94%
Free Cash Flow Margin
19.78%121.87%42.08%-118.08%-409.81%-398.31%
EBITDA
324.68-156.85253.67-92.68-130.34-125.03
EBITDA Margin
58.85%-58.39%-154.46%--
D&A For EBITDA
1.591.280.830.981.030.81
EBIT
323.1-158.13252.84-93.65-131.37-125.85
EBIT Margin
58.56%-58.20%-156.09%--
Effective Tax Rate
2.28%-1.51%---
SEC Filings: 10-K · 10-Q